Clinical Trial Update: Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.

View source ↗

Summary

This trial update reports on using PET imaging with the radiolabeled tracer [11C] dihydrotetrabenazine (DTBZ) to estimate pancreatic beta cell mass in individua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• [11C] Dihydrotetrabenazine (DTBZ) (dihydrotetrabenazine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes | Status: COMPLETED